STOCK TITAN

Lifecore Biomedical to Participate at Upcoming Industry Conferences

Lifecore Biomedical (LFCR) will participate in three upcoming industry conferences in Boston, where leaders will meet with prospective customers.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Lifecore Biomedical (LFCR) will participate in three upcoming industry conferences in Boston, where leaders will meet with prospective customers. Events include CDMO Live Americas on October 19–21, 2026; PODD on October 29–30, 2026; and the American Pharma Manufacturing & Outsourcing Summit on November 20–23, 2026. Meetings will cover process development and manufacturing services for injectable programs.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CHASKA, Minn., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at three upcoming industry events. 

At each conference, Lifecore leaders will host meetings with prospective customers to discuss process development and manufacturing services for injectable programs.  Details regarding Lifecore’s participation are as follows:

  • CDMO Live Americas:
    Booth number: C19 
    Conference Dates: October 19-21, 2026
    Location: Boston, MA

  • Partnership Opportunities in Drug Development (PODD)
    Booth number: 109
    Conference Dates: October 29-30, 2026
    Location: Boston, MA

    Ryan Swanson, Ph.D., director of Lifecore’s Manufacturing Science & Technology (MS&T) group, will be a panel speaker at the following session: 
    Designing Devices to Deliver High-Dose/High Viscosity Peptides & Biologics
    Fri, Oct 30 | 03:50 PM - 04:20 PM
    Grand Ballroom

  • American Pharma Manufacturing & Outsourcing Summit 
    Booth number: TBD
    Conference Dates: November 20-23, 2026
    Location: Boston, MA

If you are interested in meeting with Lifecore during this event, please reach out to us at: cdmo@lifecore.com.

About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Contact Information:
Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com

Jennifer Arcure (Media)
917-603-0681
jarcure@vidasp.com

Lifecore Biomedical
Ryan D. Lake (CFO)
952-368-6244
ryan.lake@lifecore.com


Keep reading